Following the intraventricular injection of 5-hydroxytryptamine into the lateral ventricles of conscious mice, the concentration of brain lactate rose imm ediately but then decreased significantly compared with the saline injected controls. The concentration of brain glucose increased 20 min after the injection of 5-hydroxytryptam ine. These effects of 5-hydroxytryptamine on lactate and glucose were qualitatively sim ilar to those found following the adm inistration of m ethysergide. After the parenteral adm inistration of 5-hydroxytryptophan, the lactate levels showed a biphasic change but brain glucose was significantly decreased for up to 90 min following the injection. p-Chlorophenylalanine potentiated the effect of 5-hydroxytryptamine by further increasing glucose and decreasing lactate levels. A fter histam ine had been injected into the ventricles, the concen trations of bound glycogen and lactate were decreased whereas free glycogen and glucose were raised.
Introduction
Evidence is now accumulating to suggest that 5-hydroxytryptamine (5-HT) as a neurotransm itter substance in the mammalain brain 1. It is assumed that the metabolic changes which occur following the physiological release of the neurohorm ones are mediated by the membrane bound adenyl cyclase system 2. In the brain, one of the most im portant functions of the cyclase system is the control of glycolysis 3' 4. The following experiments were there fore undertaken in an attempt to see what effect 5-HT had on brain glycolysis. Although there is little evidence implicating histamine as a neuro transm itter in the mammalain brain, this amine has been shown to stimulate the production of 3,5-cyclic adenosinemonophosphate (cAMP) in cerbral cortex slices 5. For this reason, the effect of histam ine on mouse brain glycolysis was also studies.
M ethods
Specific pathogen free albino mice of the Alderley P ark strain (18 -22 g, either sex) were used throughout these experiments. The mice were injected with the drug or vehicle (control group) and the oesophageal tem peratures were determined Requests for reprints should be sent to Prof. Dr. B. E. Leonard, D epartm ent of Pharm acology, University Col lege, Galway, Republic of Ireland.
at regular intervals during the experimental period by means of a thermistor probe (Light & Sons, B righton). If the temperature was reduced by more than 0.5 °C, the animals were kept in a constant temperature room at 38 °C until they were killed. The intraventricular injections of serotonin and histamine into conscious mice was performed by the method of Haley and McCormick 6.
At various times (shown in Results) after ad m inistration of the drug, groups of at least 5 mice were killed by immersion in liquid nitrogen. After thorough freezing, the mice were decapitated, their brains were rapidly chipped out, weighed and tri turated with a protein precipitating agent (general ly 10% trichloracetic acid) in a cooled glass m ortar.
After centrifugation at approximately 500 x g for 1 0 -15 min, the supernatant fraction was separated from the pellet; both fractions were kept at 0 °C until the assays were undertaken. With the excep tion of glycogen, the assays were performed on the same day as the extracts were prepared. The fol lowing determinations were made.
Glycogen. The trichloracetic acid soluble ("free" ) and insoluble ("bond" ) glycogen was treated by the method described by Russell and Bloom ' and the glucose formed after acid hydrolysis estimated by the glucose oxidase method of Hugget and Nixon 8.
Glucose and lactate were estimated by the glucose oxidase method 8 and lactic dehydrogenase method 9, respectively on aliquots of the supernatant fraction. 
R esults
The eßects of 5-hydroxytryptamine, 5-hydroxytryptophan and methylsergide on brain glycolysis
When 5-HT (5 /<g in 10 //I physiological saline) was injected into the lateral ventricles of conscious mice the animals showed pronounced head "twitch-« ing" and head trem or which lasted for up to 5 m in | after injection. The mice were then behaviourallyf depressed and showed a slowed righting reflex for** the duration of the experiment.
5-HT caused a biphasic change in the concentra tion of brain lactate; the levels were elevated 1 min after adm inistration of the amine but were then significantly depressed 5 min later (Fig. 1) . The changes in brain glucose were inversely related to those of lactate. Glycogen levels were unaffected. The behavioural and many of the neurochemical changes which occurred following the intraventricular adm inistration of 5-HT were also seen after the intraperitoneal injection of its precursor amino acid, 5-hydroxytryptophan. Frequent head shaking occurred for up to 15 min following the adm inistra tion of this amino acid (100 m g/kg), this was suc ceeded by a period of sedation, from which the animals could be easily alerted, lasting for a further 15 min. Slight hypotherm ia occurred 15 min after the drug had been administered. The changes in the lactate concentration were qualitatively similar to those seen following the adm inistration of 5-HT (Fig. 2 ) . However, after 5-hydroxytryptophan, the Effect of 5 -Hydroxytryptop h a n . concentration of brain glucose was reduced whereas the concentration of the substance was raised after the intraventricular injection of 5-HT. Methysergide has been shown to be an effective antagonist of 5-HT on peripheral tissues 10. However, from clini cal studies of migraine, there is some evidence to suggest that it has a similar action to serotonin on central tryptam ine receptors 1X > 12. It was therefore of interest to investigate the effects of this drug on mouse brain glycolysis.
Following the adm inistration of methysergide (20 mg/kg i. p.) the mice were slightly hypothermic and behaviourally depressed for up to 120 min after injection; their tem perature and behaviour returned to norm al after 180 min. Lower doses of methysergide (5 and 10 mg/kg) produced only slight depression but no hypotherm ia was apparent.
Changes in glycolysis after 20 mg/kg methysergide qualitatively resembled those seen after the ad m inistration of 5-HT (Fig. 3 ) . There was a marked increase in glucose and decrease in brain lactate which lasted for the duration of the experiment. p-Chlorophenylalanine (PCPA) has been shown to deplete brain 5-HT by inhibiting the synthesis of this amine at the tryptophan hydroxylase stage 13.
Eßect of histamine on glycolysis
The only behavioural change observed following the intraventricular administration of 10 jug in 10 //l) of histamine was slight tachypnoea and depresion from which the animals rapidly recovered.
Quite unexpectedly, histamine reduced glycolysis and produced a biphasic change in the concentra tion of glucose (Fig. 4 ) . "Bound" glycogen was elevated at first and then rapidly returned to the control level.
Discussion
It is well established that noradrenaline plays a key role in activating the adenyl cyclase system in both nervous and non nervous tissues3' 4. In a previous investigation, it was found that this amine increases glycolysis in the mouse brain and that its effect on glycolysis could be antagonized by pretreating the animals with dl-propranolol15. In that study, dopamine was found to have a qualitati vely similar effect to noradrenaline on brain glyco lysis.
In contrast to the effect of the catecholamines on brain glycolysis, 5-HT and methysergide prim arily reduce glycolysis. The similarity in the effects of 5-HT and methysergide on glycolysis is further sup port for the suggestion that they both act on similar tryptam ine receptors in the mouse brain. It was somewhat surprising to find that the amino acid precursor of 5-HT, 5-hydroxytryptophan, prim arily increases glycolysis following its parenteral ad m inistration. One explanation for this finding is that high doses of the amino acid are known to T able I. Effect of p-chlorophenylalam ine on brain glycolysis. Results expressed as /umo\/g wet weight brain. Each result represents the mean ±s.e.m . of at least 5 anim als. The signifi cance of the difference between the drug treated and the control group shown by: ** P < 0 .0 1 , *** P < 0 .0 0 1 . PCPA in jected twice daily (2 x 80 m g/kg) for two days. 5 H T in jected 10 min before anim als were killed. Groups of mice were therefore treated with 80 m g/ kg of this drug twice daily for 2 days. Other in vestigators have shown that such a treatm ent schedule significantly reduces (by approximatley 40%) the levels of brain 5-HT in m ic e 14. The animals were killed on the m orning of the third day. 10 min before one of the PCPA-treated groups was killed, the mice were injected intraventricularly with 1 0 («g 5-HT in 10 /il physiological saline. In p re vious experiments, this was found to coincide with the peak effect of 5-HT on brain glycolysis. The results of this investigation are shown in Table I . Quite unexpectedly, the reduction in endogenous 5-HT by PCPA resulted in a decrease in both glucose and lactate. In those animals which were pretreated with PCPA, the intraventricular adm ini stration of 5-HT resulted in the further reduction in the brain lactate concentration. However, the concentration of glucose increased following 5-HT injection.
Effect of H is tam in e . displace catecholamines from their storage sites in the b r a in 16. This could result in an increase in glycolysis as a consequence of the displaced cate cholamines activating the cyclase system. The failure of histamine to increase brain glyco lysis in the present investigation suggest that this amine has little effect on brain adenyl cyclase acti vity. This was also found when broken cell prepara tions from the guinea pig were incubated with histam in e17; histamine was also ineffective in stimulating pineal gland adenyl cyclase activity18. However, Kakiuchi and Rail 5, found that histamine casued a large increase in cyclic AMP levels in cerebral cortex slices of the rabbit. Clearly such equivocal results could be due to several factors, such as species differences and the relative ease of access of the amine to the enzyme surface.
Though inconclusive, the results of this study suggest that in addition to noradrenaline, the puta tive transm itter substance 5-HT may also be in volved in the control of brain glycolysis. Whether these effects are mediated by a direct action of the adenyl cyclase system or by some other mechanisms cannot be ascertained from this study.
Furtherm ore, although the present results were obtained in vivo, criticism justifiably can be made of the unphysiological conditions under which the neurohormones were administered and also the re latively high doses of some of the drugs used to produce the observed changes. Nevertheless, such a study may provide a useful starting point for further work, which could lead to a better understanding of the mechanisms by which centrally acting drugs can affect brain carbohydrate metabolism.
